Evotec Competitors and Similar CompaniesClear all
Eurofins's competitors and similar companies include Catalent.
 Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. | ||
Founding Date | Founding Date 1987 | Founding Date 2007 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Bridgewater, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more | |
Employees | Employees 65,0004% increase | Employees 12,6955% increase |
Financial | ||
Revenue (est.) | Revenue (est.) €7.3b (FY, 2025) | Revenue (est.) $4.4b (FY, 2024) |
Cost of goods | Cost of goods €2.3b (FY, 2025) | Cost of goods $3.4b (FY, 2024) |
Gross profit | Gross profit €5b (FY, 2025) | Gross profit $953m (FY, 2024) |
Net income | Net income €473m (FY, 2025) | Net income ($1b) (FY, 2024) |
Operating ⚠ | ||
Countries | Countries 62 (FY, 2023) | Countries 80 (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 30m | Total funding raised $ 650m |
For sources of this data, please see the company profile
View Company Profiles
Catalent
HQ
Bridgewater, US
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View company